Current and historical daily PE Ratio for Noile-Immune Biotech Inc (
) from 2023 to Jun 04 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Noile-Immune Biotech stock (TSE:4893) PE ratio as of Jun 04 2024 is 0.
More Details
Noile-Immune Biotech Inc (TSE:4893) PE Ratio (TTM) Chart
Noile-Immune Biotech Inc (TSE:4893) PE Ratio (TTM) Historical Data
View and export this data going back to 2023. Start your Free Trial
Total 230
- 1
- 2
- 3
| Noile-Immune Biotech PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-04 | At Loss | 2024-03-29 | At Loss |
| 2024-06-04 | At Loss | 2024-03-28 | At Loss |
| 2024-06-03 | At Loss | 2024-03-27 | At Loss |
| 2024-05-31 | At Loss | 2024-03-26 | At Loss |
| 2024-05-30 | At Loss | 2024-03-25 | At Loss |
| 2024-05-29 | At Loss | 2024-03-22 | At Loss |
| 2024-05-28 | At Loss | 2024-03-21 | At Loss |
| 2024-05-27 | At Loss | 2024-03-19 | At Loss |
| 2024-05-24 | At Loss | 2024-03-18 | At Loss |
| 2024-05-23 | At Loss | 2024-03-15 | At Loss |
| 2024-05-22 | At Loss | 2024-03-14 | At Loss |
| 2024-05-21 | At Loss | 2024-03-13 | At Loss |
| 2024-05-20 | At Loss | 2024-03-12 | At Loss |
| 2024-05-17 | At Loss | 2024-03-11 | At Loss |
| 2024-05-16 | At Loss | 2024-03-08 | At Loss |
| 2024-05-15 | At Loss | 2024-03-07 | At Loss |
| 2024-05-14 | At Loss | 2024-03-06 | At Loss |
| 2024-05-13 | At Loss | 2024-03-05 | At Loss |
| 2024-05-10 | At Loss | 2024-03-04 | At Loss |
| 2024-05-09 | At Loss | 2024-03-01 | At Loss |
| 2024-05-08 | At Loss | 2024-02-29 | At Loss |
| 2024-05-07 | At Loss | 2024-02-28 | At Loss |
| 2024-05-02 | At Loss | 2024-02-27 | At Loss |
| 2024-05-01 | At Loss | 2024-02-26 | At Loss |
| 2024-04-30 | At Loss | 2024-02-22 | At Loss |
| 2024-04-26 | At Loss | 2024-02-21 | At Loss |
| 2024-04-25 | At Loss | 2024-02-20 | At Loss |
| 2024-04-24 | At Loss | 2024-02-19 | At Loss |
| 2024-04-23 | At Loss | 2024-02-16 | At Loss |
| 2024-04-22 | At Loss | 2024-02-15 | At Loss |
| 2024-04-19 | At Loss | 2024-02-14 | At Loss |
| 2024-04-18 | At Loss | 2024-02-13 | At Loss |
| 2024-04-17 | At Loss | 2024-02-09 | At Loss |
| 2024-04-16 | At Loss | 2024-02-08 | At Loss |
| 2024-04-15 | At Loss | 2024-02-07 | At Loss |
| 2024-04-12 | At Loss | 2024-02-06 | At Loss |
| 2024-04-11 | At Loss | 2024-02-05 | At Loss |
| 2024-04-10 | At Loss | 2024-02-02 | At Loss |
| 2024-04-09 | At Loss | 2024-02-01 | At Loss |
| 2024-04-08 | At Loss | 2024-01-31 | At Loss |
| 2024-04-05 | At Loss | 2024-01-30 | At Loss |
| 2024-04-04 | At Loss | 2024-01-29 | At Loss |
| 2024-04-03 | At Loss | 2024-01-26 | At Loss |
| 2024-04-02 | At Loss | 2024-01-25 | At Loss |
| 2024-04-01 | At Loss | 2024-01-24 | At Loss |
Noile-Immune Biotech Inc (TSE:4893) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Noile-Immune Biotech Inc
ISIN : JP3759560000
Description
Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers